News &

Press

venBio news

“venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences.”

“venBio Closes $394 Million Life Sciences Venture Capital Fund.”

Portfolio news

ImmPACT Bio Appoints Biren Amin, M.B.A. to its Board of Directors

Feb 8, 2023

ImmPACT Bio Announces FDA Clearance of IND for Novel Bispecific CAR to Treat Aggressive B-cell Lymphoma

Feb 3, 2023

Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101

Jan 31, 2023

Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer

Jan 24, 2023

Ventyx Biosciences announces pipeline updates and highlights strategic priorities at investor R&D day

Jan 23, 2023

NorthSea Therapeutics provides clinical update reflecting progress across NASH and metabolic disorders programmes

Jan 5, 2023

Artiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply

Aug 12, 2021

San Francisco office

1700 Owens Street, Suite 595
San Francisco, CA 94158

Seattle office

1200 Westlake Ave N, Suite 900
Seattle, WA 98109

© 2023 venBio. All Rights Reserved.